By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Provectus Biopharmaceuticals Inc. 

7327 Oak Ridge Highway Suite B

Knoxville  Tennessee  37931  U.S.A.
Phone: 866-594-5999 Fax:


SEARCH JOBS








Company News
Provectus Biopharmaceuticals Inc.’ Data On PV-10 For Chemoablation Of Liver Cancers Presented At ESMO 17th World Congress On Gastrointestinal Cancer 7/2/2015 11:17:03 AM
Provectus Biopharmaceuticals Inc. Signs Letter Of Intent With Boehringer Ingelheim (China) To Collaborate In Bringing PV-10 To Market In China 7/2/2015 9:28:26 AM
Provectus Biopharmaceuticals Inc.’ Data On PV-10 As Treatment For Melanoma Presented At 5th European Post-Chicago Melanoma / Skin Cancer Meeting 6/26/2015 2:29:47 PM
AAPI Honors Provectus Biopharmaceuticals Inc. During 33rd Annual Convention And Scientific Assembly 6/26/2015 2:28:16 PM
Provectus Biopharmaceuticals Inc. Announces Abstract Available On PV-10 For Chemoablation Of Liver Cancers At ESMO 17th World Congress On Gastrointestinal Cancer 6/25/2015 3:44:41 PM
Provectus Biopharmaceuticals Inc.’ Poster Presentation Displayed On Phase 3 Study Of PV-10 At 5th European Post-Chicago Melanoma / Skin Cancer Meeting 6/25/2015 3:41:11 PM
Provectus Biopharmaceuticals Inc. Announces Closing Of Public Offering 6/25/2015 12:39:36 PM
Provectus Biopharmaceuticals Inc. Retains PharmaHEALTHLabs To Facilitate Investigator Advisory Board Meeting During 11Th Brazilian Melanoma Conference 6/22/2015 4:01:16 PM
Provectus Biopharmaceuticals Inc. Announces Proposed Public Offering Of Common Stock And Warrants 6/19/2015 12:38:49 PM
Provectus Biopharmaceuticals Inc. Announces Pricing Of Public Offering To Raise $13.1 Million 6/19/2015 8:04:21 AM
12345678910...
//-->